InnovAge Holding Corp (INNV) Q3 2026 Earnings Call Transcript

Why It Matters

The results demonstrate InnovAge’s ability to scale value‑based senior care profitably, signaling stronger cash flows for investors and more efficient service delivery for government payors.

Key Takeaways

• Revenue up 14.7% YoY to $239.7 million.
• Adjusted EBITDA margin reaches 9.2% target.
• Member months increase 7.9% YoY, driving growth.
• De Novo center losses total $4.7 million this quarter.
• Full-year guidance lifted: revenue $925‑950M, EBITDA $70‑75M.

Pulse Analysis

InnovAge’s latest earnings underscore how disciplined operational improvements can translate into robust financial performance within the PACE (Program of All‑Inclusive Care for the Elderly) model. By tightening Medicaid eligibility workflows, reinstating participants who lost coverage, and leveraging advanced analytics for cost management, the company reduced reserves and boosted revenue integrity. These initiatives not only lifted top‑line growth but also enabled the firm to hit its 9.2% adjusted EBITDA margin, a key benchmark for sustaining full‑risk, value‑based care operations.

The updated guidance reflects confidence in scaling the platform despite the inherent volatility of government‑funded reimbursement rates. Projected revenue of $925‑950 million and adjusted EBITDA of $70‑75 million suggest that InnovAge can continue to expand its participant base while maintaining margin discipline. However, the ongoing de Novo center losses, ranging from $4.7 million this quarter to an estimated $11.5‑13.5 million annually, highlight the capital intensity and execution risk associated with opening new sites. Investors will watch how the company balances growth through new centers against the need for profitability in its mature network.

Strategic governance shifts, including the return of Tom Scully as chairman and the addition of seasoned board members, aim to reinforce oversight as the firm pursues further clinical standardization and AI‑driven scheduling tools. These moves are designed to reduce unwarranted practice variation, improve participant experience, and lower total cost of care—critical levers for long‑term sustainability in a highly regulated senior‑care market. As Medicare and Medicaid rate dynamics evolve, InnovAge’s focus on data‑driven decision‑making positions it to adapt quickly, offering a compelling case for stakeholders seeking exposure to scalable, high‑impact healthcare delivery models.